AT-05

N/A

Report date: 2025/11/27 17:57:15
NME

Base Information

Drug NameAT-05
Drug Alias NameAT-0599m-Tc AT-05
ClassificationRadiation-emitting products > Nuclides > Technetium > 99mTcSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Diagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionEmission-computed tomography enhancersRadionuclide imaging enhancersSingle-photon emission-computed tomography enhancers +[4] 
TargetsAmyloid
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAttralus Inc
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGAttralus Inc
Inactive CompaniesN/A
Active IndicationsAmyloidosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A